(Q68389729)
Statements
Pharmacokinetic and toxicity evaluation of five-day continuous infusion versus intermittent bolus cis-diamminedichloroplatinum(II) in head and neck cancer patients (English)
Forastiere AA
Belliveau JF
Goren MP
Vogel WC
Posner MR